In cell lines from breast cancer, colon cancer, prostate cancer and lung cancer, several researchers have reported that flavonoid could induce cell cycle arrest in G2/M phase via p21CIP1/ WAF1 upregulation [18, 42–49]. Here, CDKN1A is linked to breast carcinoma.